Article

New device allows non-surgical blepharoplasty

Non-surgical blepharoplasty can provide surgeons with a minimally invasive approach to eyelid procedures.

Key Points

Marlton, NJ-Non-surgical blepharoplasty can provide surgeons with a minimally invasive approach to eyelid procedures.

Using a blepharoplasty device (EyeTight, LaserTight LLC), which is FDA cleared for lower lid blepharoplasty, the procedure is performed using local anesthesia and can be completed within 15 minutes. There is minimal downtime for the patient, and skin tightening continues for 6 to 8 weeks after the procedure.

The device uses 980-nm laser energy delivered through a customized 20-gauge endoprobe to vaporize fat cells. Other similar procedures using LaserTight devices can be performed on other parts of the body. Demand for such procedures is expected to increase.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.